2015/04/30

Nature Reviews Rheumatology - Table of Contents alert Volume 11 Issue 5

If you are unable to see the message below, click here to view.
Nature Reviews Rheumatology


Advertisement
Nature Communications is now fully open access

All new submissions if accepted, will be published open access and an article processing charge will apply. For more information visit the website.

Visit our open access funding page or contact openaccess@nature.com to learn more on APC funding.
 
 
TABLE OF CONTENTS
 
May 2015 Volume 11 Number 5

Nature Reviews Rheumatology cover
Impact Factor 10.252 *
In this issue
Research Highlights
News and Views
Reviews
Perspectives

Also this month
 Featured article:
Management of juvenile idiopathic arthritis: hitting the target
Claas Hinze, Faekah Gohar & Dirk Foell




Subscribe
 
Facebook
 
RSS
 
Recommend to library
 
Twitter
 
RESEARCH HIGHLIGHTS

Top

Osteoimmunology: IgG immune complexes directly regulate bone homeostasis
Published online: 14 April 2015
p257 | doi:10.1038/nrrheum.2015.51

PDF


Experimental arthritis: In vivo noninvasive molecular optical imaging of disease
Published online: 24 March 2015
p258 | doi:10.1038/nrrheum.2015.39

PDF


Basic research: Synovial surfaces use synergy to slide
Published online: 31 March 2015
p259 | doi:10.1038/nrrheum.2015.42

PDF


Immunology: BiP peptides induce epitope-specific T-cell reactions in RA
Published online: 31 March 2015
p259 | doi:10.1038/nrrheum.2015.43

PDF


Connective tissue diseases: ICOS sustains pathogenic T-cell survival in SLE mouse model
Published online: 07 April 2015
p260 | doi:10.1038/nrrheum.2015.49

PDF


Osteoarthritis: SIRT6 prevents chondrocyte senescence and DNA damage
Published online: 14 April 2015
p260 | doi:10.1038/nrrheum.2015.52

PDF


IN BRIEF

Pain: No effect of opioid use on response to pregabalin in FMS | Spondyloarthropathies: Minimal disease activity linked to better outcomes in PsA | Lupus nephritis: MMF not superior to AZA as maintenance therapy
PDF

Rheumatology
EVENT
10th International Congress on Autoimmunity
06.04.16
Leipzig, Germany
More science events from
 
NEWS AND VIEWS

Top
Autoimmunity: Lungs and citrullination
Lars Klareskog & Anca I. Catrina
Published online: 17 March 2015
p261 | doi:10.1038/nrrheum.2015.38
Anti-citrullinated protein antibodies are a distinctive feature of a subset of patients with rheumatoid arthritis (RA). A new report investigates how lung inflammation in patients with chronic obstructive pulmonary disease affects protein citrullination, providing an additional piece of information on the potential link between airway inflammation and RA.
Full Text | PDF


Connective tissue diseases: SLE classification: plus ca change, plus c'est la meme chose
Matthias Schneider & Matthew H. Liang
Published online: 17 February 2015
p262 | doi:10.1038/nrrheum.2015.16
The sensitivity of the long-awaited SLICC classification criteria for systemic lupus erythematosus (SLE) has now been examined in a cross-sectional observational study. Will the new criteria enable advances in the management of SLE?
Full Text | PDF


Corrigendum: Pharmacogenetics: implications for therapy in rheumatic diseases
Lesley Davila & Prabha Ranganathan
Published online: 10 March 2015
p258 | doi:10.1038/nrrheum.2015.32

Full Text | PDF


 
REVIEWS

Top
Advances in biomarkers for paediatric rheumatic diseases
Alessandro Consolaro, Giulia C. Varnier, Alberto Martini & Angelo Ravelli
Published online: 16 December 2014
p265 | doi:10.1038/nrrheum.2014.208
Promising biomarkers are being developed to predict disease outcome and response to therapy in children with juvenile idiopathic arthritis, childhood lupus nephritis and juvenile idiopathic inflammatory myopathies. These advances are expected to facilitate risk stratification, diagnosis and management of these patients, and thereby lead to more rational and effective clinical care.
Abstract | Full Text | PDF


Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challenges
Josef S. Smolen & Daniel Aletaha
Published online: 17 February 2015
p276 | doi:10.1038/nrrheum.2015.8
Targeted therapies and novel strategies to optimize their use enable many patients with RA to achieve a state of low disease activity or even remission, which can be maintained even after tapering or withdrawal of biologic DMARDs. In this article, Smolen and Aletaha review current concepts of RA treatment and the clinical evidence for their effectiveness, in the context of relevant issues such as factors influencing response to therapy, the 'window of opportunity' hypothesis and definitions of treatment targets.
Abstract | Full Text | PDF


Management of juvenile idiopathic arthritis: hitting the target
Claas Hinze, Faekah Gohar & Dirk Foell
Published online: 06 January 2015
p290 | doi:10.1038/nrrheum.2014.212
The treatment of juvenile idiopathic arthritis (JIA) has improved markedly in past years, but sustained remission off-medication is still rare. In this Review, Hinze et al. discuss existing treatment approaches and guidelines, with a focus on targeted and patient-centred therapies developed to optimize management strategies for patients with JIA.
Abstract | Full Text | PDF


The clinical spectrum of autoimmune congenital heart block
Pilar Brito-Zerón, Peter M. Izmirly, Manuel Ramos-Casals, Jill P. Buyon & Munther A. Khamashta
Published online: 24 March 2015
p301 | doi:10.1038/nrrheum.2015.29
Autoimmune congenital heart block is more likely to occur in the babies of women with rheumatic diseases, particularly women seropositive for anti-Ro or anti-La autoantibodies. Here, the authors provide advice for the management of these women and their babies in juxtaposition to a systematic assessment of the epidemiology and classification of the disease.
Abstract | Full Text | PDF | Supplementary information


 
PERSPECTIVES

Top
SCIENCE AND SOCIETY
Article series: APLAR Perspectives
A new look at rheumatology in China—opportunities and challenges
Zhan-guo Li
Published online: 20 January 2015
p313 | doi:10.1038/nrrheum.2014.218
Funding and support for research and development in China is expanding at a rapid rate. In this APLAR Perspectives article, this growth is highlighted by advances in the field of rheumatology that have been catalysed by an increase in funding for Chinese rheumatology and by international partnerships.
Abstract | Full Text | PDF


nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events
*Journal Citation Reports, Thomson, 2013. Nature Reviews Rheumatology was previously published as Nature Clinical Practice Rheumatology.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/myaccount
(You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department

For print subscription enquiries, please contact our subscription department

For other enquiries, please contact our feedback department

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group

Label Cloud

Technology (1097) News (595) Military (498) Microsoft (492) Business (487) Developer (382) Music (351) Software (318) Audio (316) Government (308) Security (300) Love (262) Books (257) Apple (236) Dungeons and Dragons (228) Funny (209) Google (194) Yahoo (186) Mobile (179) Storage (178) Adobe (176) Wishlist (159) Astrology (137) Local (137) Art (134) Investing (125) Shopping (124) AMD (105) Hardware (105) Neatorama (94) Blogger (93) Education (72) Movies (61) Mozilla (61) Dictionary (59) Weather (48) Video Games (44) Television (36) VoIP (25) meta (23) Holidays (14) Entertainment (12) Christian (11)